Du Qiang Wang

Director/Board Member at NOVOPROTEIN SCIENTIFIC INC.

39 year

Retail Trade

Consumer Services

Commercial Services

Profile

Du Qiang Wang is currently the Director at Novoprotein Scientific (Shanghai), Inc. since 2020.
He is also the Board Secretary, Director & Deputy General Manager at Suzhou Novoprotein Scientific Co., Ltd.
since 2010.
Mr. Wang graduated from Fudan University in 2017.

Du Qiang Wang active positions

Companies	Position	Start
NOVOPROTEIN SCIENTIFIC INC.	Director/Board Member	2021-04-14
Novoprotein Scientific (Shanghai), Inc. Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu.	Director/Board Member	2020-08-11

All active positions of Du Qiang Wang

Training of Du Qiang Wang

Fudan University

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Du Qiang Wang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
NOVOPROTEIN SCIENTIFIC INC.	Commercial Services

Private companies	1
Novoprotein Scientific (Shanghai), Inc. Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu.	Retail Trade